Skip to content

Clinical trials

Terminated Multiple Myeloma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Status: Terminated Country / region: United States Clear all

399 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20016
20024
20033
200413
200515
200614
200720
200831
200915
201024
201112
201223
201320
201421
201510
201622
201721
201826
201918
202023
202120
202216
20236
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated399

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Masonic Cancer Center, University of Minnesota16
National Cancer Institute (NCI)16
Celgene12
Washington University School of Medicine12
M.D. Anderson Cancer Center11
University of Arkansas10
Amgen8
Mayo Clinic8
Barbara Ann Karmanos Cancer Institute7
OHSU Knight Cancer Institute7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma399
Neoplasms, Plasma Cell77
Lymphoma74
Lymphoma, Non-Hodgkin68
Leukemia, Lymphocytic, Chronic, B-Cell66
Myelodysplastic Syndromes64
Precursor Cell Lymphoblastic Leukemia-Lymphoma61
Hodgkin Disease60
Leukemia, Myeloid, Acute60
Leukemia58

Trials

Showing 1 to 25 of 399. Each trial links to its page on Pharma Observatory.

299 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.